Proteomic profiling reveals ACTN1-mediated cytoskeletal remodelling and hyperplasia of cerebrovascular smooth muscle cells in moyamoya disease

Yaoren Chang; Zhenyu Zhou; Junze Zhang; Yuanli Zhao; Shihao He; Xun Ye

doi:10.1002/ctm2.70730

Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (7) :e70730 DOI: 10.1002/ctm2.70730

LETTER TO THE JOURNAL

Proteomic profiling reveals ACTN1-mediated cytoskeletal remodelling and hyperplasia of cerebrovascular smooth muscle cells in moyamoya disease

Author information +

History +

PDF (4078KB)

Cite this article

Download citation ▾

Yaoren Chang, Zhenyu Zhou, Junze Zhang, Yuanli Zhao, Shihao He, Xun Ye. Proteomic profiling reveals ACTN1-mediated cytoskeletal remodelling and hyperplasia of cerebrovascular smooth muscle cells in moyamoya disease. Clinical and Translational Medicine, 2026, 16 (7) : e70730 DOI:10.1002/ctm2.70730

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Scott RM. Moyamoya Disease and Moyamoya Syndrome. n engl j med. 2009; 360(12): 1226-1237.

[2]	Koh E-J, Kim H-N, Ma T-Z, et al. Comparative analysis of serum proteomes of moyamoya disease and normal controls. J Korean Neurosurg Soc. 2010; 48: 8-13.

[3]	Wang X, Han C, Jia Y, et al. Proteomic profiling of exosomes from hemorrhagic moyamoya disease and dysfunction of mitochondria in endothelial cells. Stroke. 2021; 52: 3351-3361.

[4]	He S, Zhang J, Liu Z, et al. Upregulated Cytoskeletal Proteins Promote Pathological Angiogenesis in Moyamoya Disease. Stroke. 2023; 54: 3153-3164.

[5]	He S, Zhang J, Zhou Z, et al. Serum amyloid A2–induced phenotypic switching of vascular smooth muscle cells in moyamoya disease. Journal of Neurosurgery. 2025: 1-13.

[6]	Sjöblom B, Salmazo A, Djinović-Carugo K. Alpha-actinin structure and regulation. Cell mol life sci: CMLS. 2008; 65: 2688-2701.

[7]	Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84: 767-801.

[8]	Shimokawa H, Sunamura S, Satoh K. RhoA/rho-kinase in the cardiovascular system. Circulation Research. 2016; 118: 352-366.

[9]	Kingsley K, Huff JL, Rust WL, et al. ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem Biophys Res Commun. 2002; 293: 1001-1006.

[10]	Zhan Y, Kim S, Izumi Y, et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler, Thromb, Vasc Biol. 2003; 23: 795-801.

Rights & permissions

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.